AI MARKET SCANNING

$RZLT

Rezolute Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Sep 16, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP1.92%
MAX GAP RECORD8.64%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $RZLT

EXECUTIONS2 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-09-09QUANT ALGOSELL x5$•••.•• → $•••.••1364m🔒 ENCRYPTED+6.94%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.6%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL